लोड हो रहा है...
Pharmacovigilance Considerations for Biosimilars in the USA
In 2015, five or more biosimilars may be approved in the USA. Because no two biologic medicines are identical, postapproval safety monitoring will be critical to detect potential differences in safety signals between a biosimilar, its reference product, and other biosimilars. Postapproval safety mon...
में बचाया:
| में प्रकाशित: | BioDrugs |
|---|---|
| मुख्य लेखकों: | , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Springer International Publishing
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4626527/ https://ncbi.nlm.nih.gov/pubmed/26419971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-015-0137-2 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|